GlassScriptPhysician profile
Aaron Mruk
NPI 1215508213
$6,276.90
in general payments reported to CMS, 2019-2025
32 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $698 · 2022: $1,220 · 2023: $2,377 · 2024: $1,694 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,263 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,263.27 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $647.17 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $598.92 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $597.04 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $574.43 | 2021-2024 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $538.23 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $404.73 | 2021-2024 | |
| Insulet Corporation | $280.38 | 2022-2024 | Omnipod |
| Gilead Sciences, INC. | $274.55 | 2022-2024 | |
| Pfizer INC. | $268.71 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.56 | 2021-2025 | Jardiance |
| Aurinia Pharma U.S., INC. | $233.62 | 2023 | Lupkynis |
| Astellas Pharma US INC | $232.84 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $202.57 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $163.01 | 2021-2024 | Eliquis, Camzyos |
| Mylan Specialty L.P. | $141.08 | 2022-2024 | Yupelri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $138.15 | 2022-2024 | Dovato |
| Biohaven Pharmaceuticals, INC. | $121.61 | 2021 | |
| Phathom Pharmaceuticals, INC. | $114.81 | 2024-2025 | Voquezna |
| Indivior INC. | $80.91 | 2023-2024 | Sublocade |
| Novartis Pharmaceuticals Corporation | $63.13 | 2022-2023 | |
| Scilex Pharmaceuticals INC. | $59.86 | 2022 | |
| Advanced Oxygen Therapy INC. | $44.98 | 2022-2023 | Topical Oxygen Chamber For Extremities |
| Amgen INC. | $35.67 | 2024 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $35.27 | 2022 | |
| Dexcom, INC. | $30.87 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $28.94 | 2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Hologic Sales and Service, LLC | $20.91 | 2024 | Aptima |
| Vertex Pharmaceuticals Incorporated | $19.98 | 2025 | |
| Corcept Therapeutics | $16.76 | 2024 | Korlym |
| Otsuka America Pharmaceutical, INC. | $16.41 | 2024 | Rexulti |
| Alkermes, INC. | $14.64 | 2024 | Vivitrol |
| Sanofi-Aventis U.S. LLC | $14.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Mruk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.